Rznomics will participate in the upcoming 26th ASGCT Annual Meeting held in Los Angeles. (May 17-20)

Oral presentation will be made on research results of Retinitis Pigmentosa gene therapy drug (RZ-004) (8:00 AM on May 20th, Room 502 AB),

and poster presentation on research results of anti-cancer gene therapy drugs (RZ-001, #1043) and Circular RNA (#540).

Rznomics look forward to discussion and collaboration of research results on trans-splicing ribozyme based gene therapeutics and Circular RNA.

Please refer to attachment for details.